Trial Profile
A randomized trial evaluating low-dose intracoronary adjunctive tenecteplase during primary PCI [percutaneous coronary intervention] for ST-elevation myocardial infarction (ICE-T).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2020
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms ICE-T; ICE-T-TIMI49
- 20 Nov 2019 Primary endpoint (Percent Diameter Stenosis of the Culprit Lesion Following the First Bolus of Study Drug Prior to Primary Percutaneous Coronary Intervention) has not been met as per results published in the American Journal of Cardiology
- 20 Nov 2019 Results published in the American Journal of Cardiology
- 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.